Other
Part:BBa_K3824001:Design
Designed by: Woo Rin Lee Group: iGEM21_Korea_HS (2021-09-28)
Modified Version 1 (MV1) peptide: Modified Buforin IIB (-RLLR)
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
The total charge of amino acid was consider to design the peptide.
Source
We used this peptide to deliver siRNA into lung cancer cells to induce cell death. Synthesized peptide from Anygen, a biotech company from South Korea